Michaela de Clare
Papers
1
Total Citations
161
H-Index
1
About
Dr Michaela de Clare is a pioneering researcher at the intersection of artificial intelligence and pharmaceutical science, with a primary focus on accelerating drug discovery for neglected tropical and orphan diseases. Her most celebrated contribution is the development of 'Eve', the world's first Robot Scientist, which autonomously designs, executes, and interprets high-throughput screening experiments. In her landmark 2015 paper (161 citations), de Clare demonstrated how this integrated AI-driven platform can dramatically reduce the time and cost of drug development by repurposing existing drugs for new therapeutic uses. This work has been hailed as a breakthrough in democratizing medicine, offering a viable path to treat diseases that are economically unviable for traditional pharmaceutical R&D. By combining machine learning, laboratory robotics, and systems biology, de Clare has not only validated a cheaper, faster model for drug discovery but has also inspired a new generation of researchers to harness automation for global health equity. Her achievements have earned her recognition as a leader in AI-driven biomedical innovation.
Research Focus
Key Achievements
Top Papers
- 1